Version 2.78

63643-1 In your LIFETIME, which of the following substances have you ever used?

Reference Information

Type Source Reference
Citation Regenstrief LOINC Grant, Bridget F., et al. "The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample." Drug and alcohol dependence 71.1 (2003): 7-16.

Skip Logic

If the patient indicates that the drug used is not listed, please mark 'Yes' next to 'Other' and continue to Question 2 of the NIDA-Modified ASSIST. If the patient says "Yes" to any of the drugs, proceed to Question 2 of the NIDA-Modified ASSIST.

Form Coding Instructions

Given the patient's response to the Quick Screen, the patient should not indicate "NO" for all drugs in Question 1. If they do, remind them that their answers to the Quick Screen indicated they used an illegal or prescription drug for nonmedical reasons within the past year and then repeat Question 1

Source: National Institute on Drug Abuse

Form Context

Note for Physicians: For prescription medications, please report nonmedical use only

Source: National Institute on Drug Abuse

Fully-Specified Name

Component
Drug type used in your lifetime
Property
Type
Time
Lifetime
System
^Patient
Scale
Nom
Method

Additional Names

Short Name
Lifetime drug med use

Basic Attributes

Class
H&P.HX
Type
Clinical
First Released
Version 2.36
Last Updated
Version 2.69
Change Reason
Release 2.69: METHOD_TYP: Method was removed because this is a generic concept; ANSWER_LIST_TYPE: Answer List was updated to Example to allow for Override Answer Lists in the panels; SURVEY_QUEST_SRC: This PhenX code was removed because it is no longer available in PhenX; TIME_ASPCT: Corrected the Timing to be congruent with the Component; Previous Releases: Updated Method from PhenX to reflect the original source of the content.; Updated the PhenX ID from "PhenX.<ID>" to "PX<ID>" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.

Normative Answer List LL5625-0

Answer Code Score Answer ID
Cannabis (marijuana, pot, grass, hash, etc.) a LA31122-7
Cocaine (coke, crack, etc.) b LA31123-5
Prescription stimulants (Ritalin, Concerta, Dexedrine, Adderall, diet pills, etc.) c LA31124-3
Methamphetamine (speed, crystal meth, ice, etc.) d LA31125-0
Inhalants (nitrous oxide, glue, gas, paint thinner, etc.) e LA31126-8
Sedatives or sleeping pills (Valium, Serepax, Ativan, Xanax, Librium, Rohypnol, GHB, etc.) f LA31127-6
Hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.) g LA31128-4
Street opioids (heroin, opium, etc.) h LA31129-2
Prescription opioids (fentanyl, oxycodone [OxyContin, Percocet], hydrocodone [Vicodin], methadone, buprenorphine, etc.) i LA31130-0
Other, Specify: j LA46-8

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]
62541-8 PhenX domain - Alcohol, tobacco and other substances

Language Variants Get Info

Tag Language Translation
es-MX Spanish (Mexico) Tipo de fármaco utilizado en su vida:Tipo:De por vida:^ Paciente:Nominal:
it-IT Italian (Italy) Tipo di farmaco usato nell'arco della sua vita:Tipo:Corso della vita:^Paziente:Nom:
Synonyms: Anamnesi paziente
nl-NL Dutch (Netherlands) geneesmiddelen en/of drugs ooit gebruikt:type:levenslang:^patiënt:nominaal:
Synonyms: soort
zh-CN Chinese (China) 您一生当中所使用过的药品类型:类型:一生:^患者:名义型:
Synonyms: 分类型应答;分类型结果;名义性;名称型;名词型;名词性;标称性;没有自然次序的名义型或分类型应答 医疗服务对象;客户;病人;病患;病号;超系统 - 病人 历史纪录与体格检查 历史纪录与体格检查.历史记录;历史纪录与体格检查.历史记录类;历史纪录与体格检查.历史记录类别;历史纪录与体格检查.病史;历史纪录与体格检查.病史类;历史纪录与体格检查.病史类别;历史纪录与体格检查.病史记录;历史纪录与体格检查.病史记录类;历史纪录与体格检查.病史记录类别;历史纪录与体格检查小节.历史记录;历史纪录与体格检查小节.历史记录类;历史纪录与体格检查小节.历史记录类别;历史纪录与体格检查小节.病史;历史纪录与体格检查小节.病史类;历史纪录与体格检查小节.病史类别 历史纪录与体格检查小节 型 寿命;一辈子;这辈子;有生之年;终生;终身;使用期;存在期;有效期;今生今世;今生 您一生当中所使用过的毒品类型 毒品 毒品;麻醉药;麻醉品;麻药;兴奋剂;药品 毒品类 病史与体格检查 药品类 药物 药物类

95430-5 In the past three months, how often have you used cannabis (marijuana, pot, grass, hash, etc.)?

Skip Logic

For patients who report "Never" having used any drug in the past 3 months: Go to Questions 6-8. For any recent illicit or nonmedical prescription drug use, go to Question 3.

Fully-Specified Name

Component
During the past 3Mo, how often have you used cannabis
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Normative Answer List LL5626-8

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 2 LA26460-8
Monthly 3 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 4 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95431-3 In the past three months, how often have you used cocaine (coke, crack, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you used cocaine
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Normative Answer List LL5626-8

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 2 LA26460-8
Monthly 3 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 4 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95432-1 In the past three months, how often have you used prescription stimulants (Ritalin, Concerta, Dexedrine, Adderall, diet pills, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you used prescription stimulants
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Normative Answer List LL5626-8

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 2 LA26460-8
Monthly 3 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 4 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95433-9 In the past three months, how often have you used methamphetamine (speed, crystal meth, ice, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you used methamphetamine
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Normative Answer List LL5626-8

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 2 LA26460-8
Monthly 3 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 4 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95434-7 In the past three months, how often have you used inhalants (nitrous oxide, glue, gas, paint thinner, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you used inhalants
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Normative Answer List LL5626-8

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 2 LA26460-8
Monthly 3 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 4 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95435-4 In the past three months, how often have you used sedatives or sleeping pills (Valium, Serepax, Ativan, Librium, Xanax, Rohypnol, GHB, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you used sedatives or sleeping pills
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Normative Answer List LL5626-8

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 2 LA26460-8
Monthly 3 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 4 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95436-2 In the past three months, how often have you used hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you used hallucinogens
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Normative Answer List LL5626-8

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 2 LA26460-8
Monthly 3 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 4 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95437-0 In the past three months, how often have you used street opioids (heroin, opium, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you used street opioids
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Normative Answer List LL5626-8

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 2 LA26460-8
Monthly 3 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 4 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95438-8 In the past three months, how often have you used prescription opioids (fentanyl, oxycodone [OxyContin, Percocet], hydrocodone [Vicodin], methadone, buprenorphine, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you used prescription opioids
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Normative Answer List LL5626-8

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 2 LA26460-8
Monthly 3 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 4 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95495-8 Other substances used during the past 3 months [NIDA]

Fully-Specified Name

Component
Other substances used during the past 3Mo
Property
-
Time
3Mo
System
^Patient
Scale
-
Method
NIDA

Basic Attributes

Class
PANEL.SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Subset
Panel Type
Organizer

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95494-1 Other substances used during the past 3 months

Fully-Specified Name

Component
Substances used during the past 3Mo
Property
Type
Time
Pt
System
^Patient
Scale
Nom
Method

Additional Names

Short Name
Substances used past 3Mo

Basic Attributes

Class
H&P.HX
Type
Clinical
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Example Answer List LL5631-8

Answer Code Score Answer ID
Alcohol LA28139-6
Tobacco LA31131-8
Steroids LA15260-5
Illegal/illicit drugs LA31132-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

Language Variants Get Info

Tag Language Translation
es-MX Spanish (Mexico) Sustancias utilizadas durante los últimos 3 meses:Tipo:Punto temporal:^ Paciente:Nominal:
it-IT Italian (Italy) Sostanze utilizzate negli ultimi 3Mesi:Tipo:Pt:^Paziente:Nom:
Synonyms: Anamnesi paziente Punto nel tempo (episodio) Sostanze utilizzate negli ultimi 3 mesi
zh-CN Chinese (China) 在过去3个月当中所使用过的物质:类型:时间点:^患者:名义型:
Synonyms: 分类型应答;分类型结果;名义性;名称型;名词型;名词性;标称性;没有自然次序的名义型或分类型应答 医疗服务对象;客户;病人;病患;病号;超系统 - 病人 历史纪录与体格检查 历史纪录与体格检查.历史记录;历史纪录与体格检查.历史记录类;历史纪录与体格检查.历史记录类别;历史纪录与体格检查.病史;历史纪录与体格检查.病史类;历史纪录与体格检查.病史类别;历史纪录与体格检查.病史记录;历史纪录与体格检查.病史记录类;历史纪录与体格检查.病史记录类别;历史纪录与体格检查小节.历史记录;历史纪录与体格检查小节.历史记录类;历史纪录与体格检查小节.历史记录类别;历史纪录与体格检查小节.病史;历史纪录与体格检查小节.病史类;历史纪录与体格检查小节.病史类别 历史纪录与体格检查小节 型 时刻;随机;随意;瞬间 病史与体格检查

95439-6 During the past 3 months, how often have you used other substances?

Fully-Specified Name

Component
During the past 3Mo, how often have you used other substances
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
In the past three months, how often have you used the substances you mentioned (first drug, second drug, etc)? Other - Specify:
Source
NIDA.2j

Normative Answer List LL5626-8

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 2 LA26460-8
Monthly 3 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 4 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95440-4 In the past 3 months, how often have you had a strong desire or urge to use cannabis (marijuana, pot, grass, hash, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you had a strong desire or urge to use cannabis
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
In the past 3 months, how often have you had a strong desire or urge to use cannabis (marijuana, pot, grass, hash, etc.)?
Source
NIDA.3a

Normative Answer List LL5627-6

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 3 LA26460-8
Monthly 4 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 5 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95441-2 In the past 3 months, how often have you had a strong desire or urge to use cocaine (coke, crack, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you had a strong desire or urge to use cocaine
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
In the past 3 months, how often have you had a strong desire or urge to use cocaine (coke, crack, etc.)?
Source
NIDA.3b

Normative Answer List LL5627-6

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 3 LA26460-8
Monthly 4 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 5 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95442-0 In the past 3 months, how often have you had a strong desire or urge to use prescribed amphetamine type stimulants (Ritalin, Concerta, Dexedrine, Adderall, diet pills, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you had a strong desire or urge to use prescription stimulants
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
In the past 3 months, how often have you had a strong desire or urge to use prescribed amphetamine type stimulants (Ritalin, Concerta, Dexedrine, Adderall, diet pills, etc.)?
Source
NIDA.3c

Normative Answer List LL5627-6

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 3 LA26460-8
Monthly 4 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 5 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95443-8 In the past 3 months, how often have you had a strong desire or urge to use methamphetamine (speed, crystal meth, ice, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you had a strong desire or urge to use methamphetamine
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
In the past 3 months, how often have you had a strong desire or urge to use methamphetamine (speed, crystal meth, ice, etc.)?
Source
NIDA.3d

Normative Answer List LL5627-6

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 3 LA26460-8
Monthly 4 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 5 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95444-6 In the past 3 months, how often have you had a strong desire or urge to use inhalants (nitrous oxide, glue, gas, paint thinner, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you had a strong desire or urge to use inhalants
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
In the past 3 months, how often have you had a strong desire or urge to use inhalants (nitrous oxide, glue, gas, paint thinner, etc.)?
Source
NIDA.3e

Normative Answer List LL5627-6

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 3 LA26460-8
Monthly 4 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 5 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95445-3 In the past 3 months, how often have you had a strong desire or urge to use sedatives or sleeping pills (Valium, Serepax, Ativan, Librium, Xanax, Rohypnol, GHB, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you had a strong desire or urge to use sedatives or sleeping pills
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
In the past 3 months, how often have you had a strong desire or urge to use sedatives or sleeping pills (Valium, Serepax, Ativan, Librium, Xanax, Rohypnol, GHB, etc.)?
Source
NIDA.3f

Normative Answer List LL5627-6

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 3 LA26460-8
Monthly 4 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 5 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95446-1 In the past 3 months, how often have you had a strong desire or urge to use hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you had a strong desire or urge to use hallucinogens
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
In the past 3 months, how often have you had a strong desire or urge to use hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.)?
Source
NIDA.3g

Normative Answer List LL5627-6

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 3 LA26460-8
Monthly 4 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 5 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95447-9 In the past 3 months, how often have you had a strong desire or urge to use street opioids (heroin, opium, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you had a strong desire or urge to use street opioids
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
In the past 3 months, how often have you had a strong desire or urge to use street opioids (heroin, opium, etc.)?
Source
NIDA.3h

Normative Answer List LL5627-6

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 3 LA26460-8
Monthly 4 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 5 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95448-7 In the past 3 months, how often have you had a strong desire or urge to use prescribed opioids (fentanyl, oxycodone [OxyContin, Percocet], hydrocodone [Vicodin], methadone, buprenorphine, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you had a strong desire or urge to use prescription opioids
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
In the past 3 months, how often have you had a strong desire or urge to use prescribed opioids (fentanyl, oxycodone [OxyContin, Percocet], hydrocodone [Vicodin], methadone, buprenorphine, etc.)?
Source
NIDA.3i

Normative Answer List LL5627-6

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 3 LA26460-8
Monthly 4 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 5 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95496-6 Other substances that you have had a strong desire or urge to use in the past 3 months [NIDA]

Fully-Specified Name

Component
Other substances that you have had a strong desire or urge to use in the past 3Mo
Property
-
Time
3Mo
System
^Patient
Scale
-
Method
NIDA

Basic Attributes

Class
PANEL.SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Subset
Panel Type
Organizer

Survey Question

Source
NIDA.3j

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95500-5 Other substances you have had a strong desire or urge to use during the past 3 months

Fully-Specified Name

Component
Substances you have had a strong desire or urge to use during the past 3Mo
Property
Type
Time
3Mo
System
^Patient
Scale
Nom
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Source
NIDA.3j

Example Answer List LL5631-8

Answer Code Score Answer ID
Alcohol LA28139-6
Tobacco LA31131-8
Steroids LA15260-5
Illegal/illicit drugs LA31132-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95449-5 During the past 3 months, how often have you had a strong desire or urge to use other substances?

Fully-Specified Name

Component
During the past 3Mo, how often have you had a strong desire or urge to use other substances
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
In the past 3 months, how often have you had a strong desire or urge to use (first drug, second drug, etc)? Other - Specify:
Source
NIDA.3j

Normative Answer List LL5627-6

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 3 LA26460-8
Monthly 4 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 5 LA18891-4
Daily or almost daily 6 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95450-3 During the past 3 months, how often has your use of cannabis (marijuana, pot, grass, hash, etc.) led to health, social, legal or financial problems?

Fully-Specified Name

Component
During the past 3Mo, how often has your use of cannabis led to health, social, legal or financial problems
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often has your use of cannabis (marijuana, pot, grass, hash, etc.) led to health, social, legal or financial problems?
Source
NIDA.4a

Normative Answer List LL5628-4

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 4 LA26460-8
Monthly 5 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 6 LA18891-4
Daily or almost daily 7 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95451-1 During the past 3 months, how often has your use of cocaine (coke, crack, etc.) led to health, social, legal or financial problems?

Fully-Specified Name

Component
During the past 3Mo, how often has your use of cocaine led to health, social, legal or financial problems
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often has your use of cocaine (coke, crack, etc.) led to health, social, legal or financial problems?
Source
NIDA.4b

Normative Answer List LL5628-4

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 4 LA26460-8
Monthly 5 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 6 LA18891-4
Daily or almost daily 7 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95452-9 During the past 3 months, how often has your use of prescribed amphetamine type stimulants (Ritalin, Concerta, Dexedrine, Adderall, diet pills, etc.) led to health, social, legal or financial problems?

Fully-Specified Name

Component
During the past 3Mo, how often has your use of prescription stimulants led to health, social, legal or financial problems
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often has your use of prescribed amphetamine type stimulants (Ritalin, Concerta, Dexedrine, Adderall, diet pills, etc.) led to health, social, legal or financial problems?
Source
NIDA.4c

Normative Answer List LL5628-4

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 4 LA26460-8
Monthly 5 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 6 LA18891-4
Daily or almost daily 7 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95453-7 During the past 3 months, how often has your use of methamphetamine (speed, crystal meth, ice, etc.) led to health, social, legal or financial problems?

Fully-Specified Name

Component
During the past 3Mo, how often has your use of methamphetamine led to health, social, legal or financial problems
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often has your use of methamphetamine (speed, crystal meth, ice, etc.) led to health, social, legal or financial problems?
Source
NIDA.4d

Normative Answer List LL5628-4

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 4 LA26460-8
Monthly 5 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 6 LA18891-4
Daily or almost daily 7 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95454-5 During the past 3 months, how often has your use of inhalants (nitrous oxide, glue, gas, paint thinner, etc.) led to health, social, legal or financial problems?

Fully-Specified Name

Component
During the past 3Mo, how often has your use of inhalants led to health, social, legal or financial problems
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often has your use of inhalants (nitrous oxide, glue, gas, paint thinner, etc.) led to health, social, legal or financial problems?
Source
NIDA.4e

Normative Answer List LL5628-4

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 4 LA26460-8
Monthly 5 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 6 LA18891-4
Daily or almost daily 7 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95455-2 During the past 3 months, how often has your use of sedatives or sleeping pills (Valium, Serepax, Ativan, Librium, Xanax, Rohypnol, GHB, etc.) led to health, social, legal or financial problems?

Fully-Specified Name

Component
During the past 3Mo, how often has your use of sedatives or sleeping pills led to health, social, legal or financial problems
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often has your use of sedatives or sleeping pills (Valium, Serepax, Ativan, Librium, Xanax, Rohypnol, GHB, etc.) led to health, social, legal or financial problems?
Source
NIDA.4f

Normative Answer List LL5628-4

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 4 LA26460-8
Monthly 5 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 6 LA18891-4
Daily or almost daily 7 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95456-0 During the past 3 months, how often has your use of hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.) led to health, social, legal or financial problems?

Fully-Specified Name

Component
During the past 3Mo, how often has your use of hallucinogens led to health, social, legal or financial problems
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often has your use of hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.) led to health, social, legal or financial problems?
Source
NIDA.4g

Normative Answer List LL5628-4

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 4 LA26460-8
Monthly 5 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 6 LA18891-4
Daily or almost daily 7 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95457-8 During the past 3 months, how often has your use of street opioids (heroin, opium, etc.) led to health, social, legal or financial problems?

Fully-Specified Name

Component
During the past 3Mo, how often has your use of street opioids led to health, social, legal or financial problems
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often has your use of street opioids (heroin, opium, etc.) led to health, social, legal or financial problems?
Source
NIDA.4h

Normative Answer List LL5628-4

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 4 LA26460-8
Monthly 5 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 6 LA18891-4
Daily or almost daily 7 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95458-6 During the past 3 months, how often has your use of prescribed opioids (fentanyl, oxycodone [OxyContin, Percocet], hydrocodone [Vicodin], methadone, buprenorphine, etc.) led to health, social, legal or financial problems?

Fully-Specified Name

Component
During the past 3Mo, how often has your use of prescription opioids led to health, social, legal or financial problems
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often has your use of prescribed opioids (fentanyl, oxycodone [OxyContin, Percocet], hydrocodone [Vicodin], methadone, buprenorphine, etc.) led to health, social, legal or financial problems?
Source
NIDA.4i

Normative Answer List LL5628-4

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 4 LA26460-8
Monthly 5 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 6 LA18891-4
Daily or almost daily 7 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95497-4 Other substances that have led to health, social, legal or financial problems in the past 3 months [NIDA]

Fully-Specified Name

Component
Other substances that have led to health, social, legal or financial problems in the past 3Mo
Property
-
Time
3Mo
System
^Patient
Scale
-
Method
NIDA

Basic Attributes

Class
PANEL.SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Subset
Panel Type
Organizer

Survey Question

Source
NIDA.4j

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95501-3 Other substances that have led to health, social, legal or financial problems during the past 3 months

Fully-Specified Name

Component
Substances that have led to health, social, legal or financial problems during the past 3Mo
Property
Type
Time
3Mo
System
^Patient
Scale
Nom
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Source
NIDA.4j

Example Answer List LL5631-8

Answer Code Score Answer ID
Alcohol LA28139-6
Tobacco LA31131-8
Steroids LA15260-5
Illegal/illicit drugs LA31132-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95459-4 During the past 3 months, how often has your use of other substances led to health, social, legal or financial problems?

Fully-Specified Name

Component
During the past 3Mo, how often has your use of other substances led to health, social, legal or financial problems
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often has your use of (first drug, second drug, etc) led to health, social, legal or financial problems? Other - Specify:
Source
NIDA.4j

Normative Answer List LL5628-4

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 4 LA26460-8
Monthly 5 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 6 LA18891-4
Daily or almost daily 7 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95460-2 During the past 3 months, how often have you failed to do what was normally expected of you because of your use of cannabis (marijuana, pot, grass, hash, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of cannabis
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often have you failed to do what was normally expected of you because of your use of cannabis (marijuana, pot, grass, hash, etc.)?
Source
NIDA.5a

Normative Answer List LL5629-2

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 5 LA26460-8
Monthly 6 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 7 LA18891-4
Daily or almost daily 8 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95461-0 During the past 3 months, how often have you failed to do what was normally expected of you because of your use of cocaine (coke, crack, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of cocaine
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often have you failed to do what was normally expected of you because of your use of cocaine (coke, crack, etc.)?
Source
NIDA.5b

Normative Answer List LL5629-2

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 5 LA26460-8
Monthly 6 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 7 LA18891-4
Daily or almost daily 8 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95462-8 During the past 3 months, how often have you failed to do what was normally expected of you because of your use of prescribed amphetamine type stimulants (Ritalin, Concerta, Dexedrine, Adderall, diet pills, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of prescribed Amphetamine type stimulants
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often have you failed to do what was normally expected of you because of your use of prescribed amphetamine type stimulants (Ritalin, Concerta, Dexedrine, Adderall, diet pills, etc.)?
Source
NIDA.5c

Normative Answer List LL5629-2

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 5 LA26460-8
Monthly 6 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 7 LA18891-4
Daily or almost daily 8 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95463-6 During the past 3 months, how often have you failed to do what was normally expected of you because of your use of methamphetamine (speed, crystal meth, ice, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of methamphetamine
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often have you failed to do what was normally expected of you because of your use of methamphetamine (speed, crystal meth, ice, etc.)?
Source
NIDA.5d

Normative Answer List LL5629-2

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 5 LA26460-8
Monthly 6 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 7 LA18891-4
Daily or almost daily 8 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95464-4 During the past 3 months, how often have you failed to do what was normally expected of you because of your use of inhalants (nitrous oxide, glue, gas, paint thinner, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of inhalants
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often have you failed to do what was normally expected of you because of your use of inhalants (nitrous oxide, glue, gas, paint thinner, etc.)?
Source
NIDA.5e

Normative Answer List LL5629-2

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 5 LA26460-8
Monthly 6 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 7 LA18891-4
Daily or almost daily 8 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95465-1 During the past 3 months, how often have you failed to do what was normally expected of you because of your use of sedatives or sleeping pills (Valium, Serepax, Ativan, Librium, Xanax, Rohypnol, GHB, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of sedatives or sleeping pills
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often have you failed to do what was normally expected of you because of your use of sedatives or sleeping pills (Valium, Serepax, Ativan, Librium, Xanax, Rohypnol, GHB, etc.)?
Source
NIDA.5f

Normative Answer List LL5629-2

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 5 LA26460-8
Monthly 6 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 7 LA18891-4
Daily or almost daily 8 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95466-9 During the past 3 months, how often have you failed to do what was normally expected of you because of your use of hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.)? etc.)

Fully-Specified Name

Component
During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of hallucinogens
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often have you failed to do what was normally expected of you because of your use of hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.)? etc.)
Source
NIDA.5g

Normative Answer List LL5629-2

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 5 LA26460-8
Monthly 6 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 7 LA18891-4
Daily or almost daily 8 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95467-7 During the past 3 months, how often have you failed to do what was normally expected of you because of your use of street opioids (heroin, opium, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of street opioids
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often have you failed to do what was normally expected of you because of your use of street opioids (heroin, opium, etc.)?
Source
NIDA.5h

Normative Answer List LL5629-2

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 5 LA26460-8
Monthly 6 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 7 LA18891-4
Daily or almost daily 8 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95468-5 During the past 3 months, how often have you failed to do what was normally expected of you because of your use of prescribed opioids (fentanyl, oxycodone [OxyContin, Percocet], hydrocodone [Vicodin], methadone, buprenorphine, etc.)?

Fully-Specified Name

Component
During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of prescription opioids
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often have you failed to do what was normally expected of you because of your use of prescribed opioids (fentanyl, oxycodone [OxyContin, Percocet], hydrocodone [Vicodin], methadone, buprenorphine, etc.)?
Source
NIDA.5i

Normative Answer List LL5629-2

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 5 LA26460-8
Monthly 6 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 7 LA18891-4
Daily or almost daily 8 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95498-2 Other substances that have caused you to fail to do what was normally expected of you in the past 3 months [NIDA]

Fully-Specified Name

Component
Other substances that have caused you to fail to do what was normally expected of you in the past 3Mo
Property
-
Time
3Mo
System
^Patient
Scale
-
Method
NIDA

Basic Attributes

Class
PANEL.SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Subset
Panel Type
Organizer

Survey Question

Source
NIDA.5j

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95502-1 Other substances that have caused you to fail to do what was normally expected of you during the past 3 months

Fully-Specified Name

Component
Substances that have caused you to fail to do what was normally expected of you during the past 3Mo
Property
Type
Time
3Mo
System
^Patient
Scale
Nom
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Source
NIDA.5j

Example Answer List LL5631-8

Answer Code Score Answer ID
Alcohol LA28139-6
Tobacco LA31131-8
Steroids LA15260-5
Illegal/illicit drugs LA31132-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95469-3 During the past 3 months, how often have you failed to do what was normally expected of you because of your use of other substances

Fully-Specified Name

Component
During the past 3Mo, how often have you failed to do what was normally expected of you because of your use of other substances
Property
Find
Time
3Mo
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
During the past 3 months, how often have you failed to do what was normally expected of you because of your use of (first drug, second drug, etc)? Other - Specify:
Source
NIDA.5j

Normative Answer List LL5629-2

Answer Code Score Answer ID
Never 0 LA6270-8
Once or twice 5 LA26460-8
Monthly 6 LA18876-5
Weekly Copyright http://snomed.info/sct ID:14497002 weekly (qualifier value) 7 LA18891-4
Daily or almost daily 8 LA18934-2

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95470-1 Has a friend or relative or anyone else ever expressed concern about your use of cannabis (marijuana, pot, grass, hash, etc.)?

Form Coding Instructions

Ask Questions 6 & 7 for all substances ever used (i.e., those endorsed in the Question 1)

Source: National Institute on Drug Abuse

Fully-Specified Name

Component
Has a friend or relative or anyone else ever expressed concern about your use of cannabis
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Has a friend or relative or anyone else ever expressed concern about your use of cannabis (marijuana, pot, grass, hash, etc.)?
Source
NIDA.6a

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95471-9 Has a friend or relative or anyone else ever expressed concern about your use of cocaine (coke, crack, etc.)?

Fully-Specified Name

Component
Has a friend or relative or anyone else ever expressed concern about your use of cocaine
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Has a friend or relative or anyone else ever expressed concern about your use of cocaine (coke, crack, etc.)?
Source
NIDA.6b

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95472-7 Has a friend or relative or anyone else ever expressed concern about your use of prescribed amphetamine type stimulants (Ritalin, Concerta, Dexedrine, Adderall, diet pills, etc.)?

Fully-Specified Name

Component
Has a friend or relative or anyone else ever expressed concern about your use of prescribed Amphetamine type stimulants
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Has a friend or relative or anyone else ever expressed concern about your use of prescribed amphetamine type stimulants (Ritalin, Concerta, Dexedrine, Adderall, diet pills, etc.)?
Source
NIDA.6c

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95473-5 Has a friend or relative or anyone else ever expressed concern about your use of methamphetamine (speed, crystal meth, ice, etc.)?

Fully-Specified Name

Component
Has a friend or relative or anyone else ever expressed concern about your use of methamphetamine
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Has a friend or relative or anyone else ever expressed concern about your use of methamphetamine (speed, crystal meth, ice, etc.)?
Source
NIDA.6d

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95474-3 Has a friend or relative or anyone else ever expressed concern about your use of inhalants (nitrous oxide, glue, gas, paint thinner, etc.)?

Fully-Specified Name

Component
Has a friend or relative or anyone else ever expressed concern about your use of inhalants
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Has a friend or relative or anyone else ever expressed concern about your use of inhalants (nitrous oxide, glue, gas, paint thinner, etc.)?
Source
NIDA.6e

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95475-0 Has a friend or relative or anyone else ever expressed concern about your use of sedatives or sleeping pills (Valium, Serepax, Xanax, Ativan, Librium, Rohypnol, GHB, etc.)?

Fully-Specified Name

Component
Has a friend or relative or anyone else ever expressed concern about your use of sedatives or sleeping pills
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Has a friend or relative or anyone else ever expressed concern about your use of sedatives or sleeping pills (Valium, Serepax, Xanax, Ativan, Librium, Rohypnol, GHB, etc.)?
Source
NIDA.6f

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95476-8 Has a friend or relative or anyone else ever expressed concern about your use of hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.)?

Fully-Specified Name

Component
Has a friend or relative or anyone else ever expressed concern about your use of hallucinogens
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Has a friend or relative or anyone else ever expressed concern about your use of hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.)?
Source
NIDA.6g

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95477-6 Has a friend or relative or anyone else ever expressed concern about your use of street opioids (heroin, opium, etc.)?

Fully-Specified Name

Component
Has a friend or relative or anyone else ever expressed concern about your use of street opioids
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Has a friend or relative or anyone else ever expressed concern about your use of street opioids (heroin, opium, etc.)?
Source
NIDA.6h

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95478-4 Has a friend or relative or anyone else ever expressed concern about your use of prescribed opioids (fentanyl, oxycodone [OxyContin, Percocet], hydrocodone [Vicodin], methadone, buprenorphine, etc.)?

Fully-Specified Name

Component
Has a friend or relative or anyone else ever expressed concern about your use of prescription opioids
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Has a friend or relative or anyone else ever expressed concern about your use of prescribed opioids (fentanyl, oxycodone [OxyContin, Percocet], hydrocodone [Vicodin], methadone, buprenorphine, etc.)?
Source
NIDA.6i

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95480-0 Other substances that have caused a friend or relative or anyone else to ever express concern about your use of other substances [NIDA]

Fully-Specified Name

Component
Other substances that have caused a friend or relative or anyone else to ever express concern about your use of other substances
Property
-
Time
Pt
System
^Patient
Scale
-
Method
NIDA

Basic Attributes

Class
PANEL.SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Subset
Panel Type
Organizer

Survey Question

Source
NIDA.6j

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95481-8 Other substances that have caused a friend or relative or anyone else to ever express concern about your use

Fully-Specified Name

Component
Substances that have caused a friend or relative or anyone else to ever express concern about your use
Property
Type
Time
Pt
System
^Patient
Scale
Nom
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Source
NIDA.6j

Example Answer List LL5631-8

Answer Code Score Answer ID
Alcohol LA28139-6
Tobacco LA31131-8
Steroids LA15260-5
Illegal/illicit drugs LA31132-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95479-2 Has a friend or relative or anyone else ever expressed concern about your use of other substances?

Fully-Specified Name

Component
Has a friend or relative or anyone else ever expressed concern about your use of other substances
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Has a friend or relative or anyone else ever expressed concern about your use of (first drug, second drug, etc)? Other - Specify:
Source
NIDA.6j

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95482-6 Have you ever tried and failed to control, cut down or stop using cannabis (marijuana, pot, grass, hash, etc.)?

Fully-Specified Name

Component
Have you ever tried and failed to control, cut down or stop using cannabis
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Have you ever tried and failed to control, cut down or stop using cannabis (marijuana, pot, grass, hash, etc.)?
Source
NIDA.7a

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95483-4 Have you ever tried and failed to control, cut down or stop using cocaine (coke, crack, etc.)?

Fully-Specified Name

Component
Have you ever tried and failed to control, cut down or stop using cocaine
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Have you ever tried and failed to control, cut down or stop using cocaine (coke, crack, etc.)?
Source
NIDA.7b

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95484-2 Have you ever tried and failed to control, cut down or stop using prescribed amphetamine type stimulants (Ritalin, Concerta, Dexedrine, Adderall, diet pills, etc.)?

Fully-Specified Name

Component
Have you ever tried and failed to control, cut down or stop using prescribed Amphetamine type stimulants
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Have you ever tried and failed to control, cut down or stop using prescribed amphetamine type stimulants (Ritalin, Concerta, Dexedrine, Adderall, diet pills, etc.)?
Source
NIDA.7c

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95485-9 Have you ever tried and failed to control, cut down or stop using methamphetamine (speed, crystal meth, ice, etc.)?

Fully-Specified Name

Component
Have you ever tried and failed to control, cut down or stop using methamphetamine
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Have you ever tried and failed to control, cut down or stop using methamphetamine (speed, crystal meth, ice, etc.)?
Source
NIDA.7d

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95486-7 Have you ever tried and failed to control, cut down or stop using inhalants (nitrous oxide, glue, gas, paint thinner, etc.)?

Fully-Specified Name

Component
Have you ever tried and failed to control, cut down or stop using inhalants
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Have you ever tried and failed to control, cut down or stop using inhalants (nitrous oxide, glue, gas, paint thinner, etc.)?
Source
NIDA.7e

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95487-5 Have you ever tried and failed to control, cut down or stop using sedatives or sleeping pills (Valium, Serepax, Xanax, Ativan, Librium, Rohypnol, GHB, etc.)?

Fully-Specified Name

Component
Have you ever tried and failed to control, cut down or stop using sedatives or sleeping pills
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Have you ever tried and failed to control, cut down or stop using sedatives or sleeping pills (Valium, Serepax, Xanax, Ativan, Librium, Rohypnol, GHB, etc.)?
Source
NIDA.7f

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95488-3 Have you ever tried and failed to control, cut down or stop using hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.)?

Fully-Specified Name

Component
Have you ever tried and failed to control, cut down or stop using hallucinogens
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Have you ever tried and failed to control, cut down or stop using hallucinogens (LSD, acid, mushrooms, PCP, Special K, ecstasy, etc.)?
Source
NIDA.7g

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95489-1 Have you ever tried and failed to control, cut down or stop using street opioids (heroin, opium, etc.)?

Fully-Specified Name

Component
Have you ever tried and failed to control, cut down or stop using street opioids
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Have you ever tried and failed to control, cut down or stop using street opioids (heroin, opium, etc.)?
Source
NIDA.7h

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95490-9 Have you ever tried and failed to control, cut down or stop using prescribed opioids (fentanyl, oxycodone [OxyContin, Percocet], hydrocodone [Vicodin], methadone, buprenorphine, etc.)?

Fully-Specified Name

Component
Have you ever tried and failed to control, cut down or stop using prescription opioids
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Have you ever tried and failed to control, cut down or stop using prescribed opioids (fentanyl, oxycodone [OxyContin, Percocet], hydrocodone [Vicodin], methadone, buprenorphine, etc.)?
Source
NIDA.7i

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95499-0 Other substances that you have ever tried and failed to control, cut down or stop using [NIDA]

Fully-Specified Name

Component
Other substances that you have ever tried and failed to control, cut down or stop using
Property
-
Time
Pt
System
^Patient
Scale
-
Method
NIDA

Basic Attributes

Class
PANEL.SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Subset
Panel Type
Organizer

Survey Question

Source
NIDA.7j

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95503-9 Other substances that you have ever tried and failed to control, cut down or stop using

Fully-Specified Name

Component
Substances that you have ever tried and failed to control, cut down or stop using
Property
Type
Time
Pt
System
^Patient
Scale
Nom
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Source
NIDA.7j

Example Answer List LL5631-8

Answer Code Score Answer ID
Alcohol LA28139-6
Tobacco LA31131-8
Steroids LA15260-5
Illegal/illicit drugs LA31132-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95491-7 Have you ever tried and failed to control, cut down or stop using other substances?

Fully-Specified Name

Component
Have you ever tried and failed to control, cut down or stop using other substances
Property
Find
Time
Pt
System
^Patient
Scale
Ord
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Survey Question

Text
Have you ever tried and failed to control, cut down or stop using (first drug, second drug, etc)? Other - Specify:
Source
NIDA.7j

Normative Answer List LL5639-1

Answer Code Score Answer ID
No, never 0 LA18386-5
Yes, but not in the past 3 months 3 LA31150-8
Yes, in the past 3 months 6 LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

95492-5 Have you ever used any drug by injection (NONMEDICAL USE ONLY)?

Form Coding Instructions

Ask Question 8 if the patient endorses any drug that might be injected, including those that might be listed in the other category (e.g., steroids)

Source: National Institute on Drug Abuse

Fully-Specified Name

Component
Injection drug use
Property
Find
Time
Lifetime
System
^Patient
Scale
Ord
Method

Additional Names

Short Name
Injection drug use Lifetime

Basic Attributes

Class
H&P.HX
Type
Clinical
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Normative Answer List LL5640-9

Answer Code Score Answer ID
No, never LA18386-5
Yes, but not in the past 3 months LA31150-8
Yes, in the past 3 months LA31151-6

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

Language Variants Get Info

Tag Language Translation
es-MX Spanish (Mexico) Uso de drogas inyectables:Tipo:De por vida:^ Paciente:Ordinal:
it-IT Italian (Italy) Uso di droghe per iniezione:Osservazione:Corso della vita:^Paziente:Ord:
Synonyms: Anamnesi Osservazione paziente Uso di droghe iniettabili
zh-CN Chinese (China) 静脉吸毒:发现:一生:^患者:序数型:
Synonyms: 依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型 医疗服务对象;客户;病人;病患;病号;超系统 - 病人 历史纪录与体格检查 历史纪录与体格检查.历史记录;历史纪录与体格检查.历史记录类;历史纪录与体格检查.历史记录类别;历史纪录与体格检查.病史;历史纪录与体格检查.病史类;历史纪录与体格检查.病史类别;历史纪录与体格检查.病史记录;历史纪录与体格检查.病史记录类;历史纪录与体格检查.病史记录类别;历史纪录与体格检查小节.历史记录;历史纪录与体格检查小节.历史记录类;历史纪录与体格检查小节.历史记录类别;历史纪录与体格检查小节.病史;历史纪录与体格检查小节.病史类;历史纪录与体格检查小节.病史类别 历史纪录与体格检查小节 发现是一个原子型临床观察指标，并不是作为印象的概括陈述。体格检查、病史、系统检查及其他此类观察指标的属性均为发现。它们的标尺对于编码型发现可能是名义型，而对于叙述型文本之中所报告的发现，则可能是叙述型。;发现物;所见;结果;结论 寿命;一辈子;这辈子;有生之年;终生;终身;使用期;存在期;有效期;今生今世;今生 毒品 毒品;麻醉药;麻醉品;麻药;兴奋剂;药品 毒品类 注射毒品使用;静脉注射毒品;静脉注射吸毒 病史与体格检查 药品类 药物 药物（毒品、麻醉药、麻醉品、麻药、兴奋剂、药品）使用（利用、服用） 药物类

95493-3 Cannabis substance involvement score [NIDA]

Term Description

The NIDA-Modified ASSIST Substance Involvement (SI) Score informs the patient's risk level for illicit or nonmedical prescription drug use. A SI score of 0-3 indicates Lower Risk; 4-26 indicates Moderate Risk; and 27 or greater indicates High Risk.
Source: National Institute on Drug Abuse

Fully-Specified Name

Component
Cannabis substance involvement score
Property
Score
Time
Pt
System
^Patient
Scale
Qn
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

Example Units

Unit Source
{score} Example UCUM Units

95504-7 Cocaine substance involvement score [NIDA]

Term Description

The NIDA-Modified ASSIST Substance Involvement (SI) Score informs the patient's risk level for illicit or nonmedical prescription drug use. A SI score of 0-3 indicates Lower Risk; 4-26 indicates Moderate Risk; and 27 or greater indicates High Risk.
Source: National Institute on Drug Abuse

Fully-Specified Name

Component
Cocaine substance involvement score
Property
Score
Time
Pt
System
^Patient
Scale
Qn
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

Example Units

Unit Source
{score} Example UCUM Units

95505-4 Prescription stimulants substance involvement score [NIDA]

Term Description

The NIDA-Modified ASSIST Substance Involvement (SI) Score informs the patient's risk level for illicit or nonmedical prescription drug use. A SI score of 0-3 indicates Lower Risk; 4-26 indicates Moderate Risk; and 27 or greater indicates High Risk.
Source: National Institute on Drug Abuse

Fully-Specified Name

Component
Prescription stimulants substance involvement score
Property
Score
Time
Pt
System
^Patient
Scale
Qn
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

Example Units

Unit Source
{score} Example UCUM Units

95506-2 Methamphetamine substance involvement score [NIDA]

Term Description

The NIDA-Modified ASSIST Substance Involvement (SI) Score informs the patient's risk level for illicit or nonmedical prescription drug use. A SI score of 0-3 indicates Lower Risk; 4-26 indicates Moderate Risk; and 27 or greater indicates High Risk.
Source: National Institute on Drug Abuse

Fully-Specified Name

Component
Methamphetamine substance involvement score
Property
Score
Time
Pt
System
^Patient
Scale
Qn
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

Example Units

Unit Source
{score} Example UCUM Units

95507-0 Inhalants substance involvement score [NIDA]

Term Description

The NIDA-Modified ASSIST Substance Involvement (SI) Score informs the patient's risk level for illicit or nonmedical prescription drug use. A SI score of 0-3 indicates Lower Risk; 4-26 indicates Moderate Risk; and 27 or greater indicates High Risk.
Source: National Institute on Drug Abuse

Fully-Specified Name

Component
Inhalants substance involvement score
Property
Score
Time
Pt
System
^Patient
Scale
Qn
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

Example Units

Unit Source
{score} Example UCUM Units

95508-8 Sedatives or sleeping pills substance involvement score [NIDA]

Term Description

The NIDA-Modified ASSIST Substance Involvement (SI) Score informs the patient's risk level for illicit or nonmedical prescription drug use. A SI score of 0-3 indicates Lower Risk; 4-26 indicates Moderate Risk; and 27 or greater indicates High Risk.
Source: National Institute on Drug Abuse

Fully-Specified Name

Component
Sedatives or sleeping pills substance involvement score
Property
Score
Time
Pt
System
^Patient
Scale
Qn
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

Example Units

Unit Source
{score} Example UCUM Units

95509-6 Hallucinogens substance involvement score [NIDA]

Term Description

The NIDA-Modified ASSIST Substance Involvement (SI) Score informs the patient's risk level for illicit or nonmedical prescription drug use. A SI score of 0-3 indicates Lower Risk; 4-26 indicates Moderate Risk; and 27 or greater indicates High Risk.
Source: National Institute on Drug Abuse

Fully-Specified Name

Component
Hallucinogens substance involvement score
Property
Score
Time
Pt
System
^Patient
Scale
Qn
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

Example Units

Unit Source
{score} Example UCUM Units

95510-4 Street opioids substance involvement score [NIDA]

Term Description

The NIDA-Modified ASSIST Substance Involvement (SI) Score informs the patient's risk level for illicit or nonmedical prescription drug use. A SI score of 0-3 indicates Lower Risk; 4-26 indicates Moderate Risk; and 27 or greater indicates High Risk.
Source: National Institute on Drug Abuse

Fully-Specified Name

Component
Street opioids substance involvement score
Property
Score
Time
Pt
System
^Patient
Scale
Qn
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

Example Units

Unit Source
{score} Example UCUM Units

95511-2 Prescription opioids substance involvement score [NIDA]

Term Description

The NIDA-Modified ASSIST Substance Involvement (SI) Score informs the patient's risk level for illicit or nonmedical prescription drug use. A SI score of 0-3 indicates Lower Risk; 4-26 indicates Moderate Risk; and 27 or greater indicates High Risk.
Source: National Institute on Drug Abuse

Fully-Specified Name

Component
Prescription opioids substance involvement score
Property
Score
Time
Pt
System
^Patient
Scale
Qn
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

Example Units

Unit Source
{score} Example UCUM Units

95512-0 Other substance involvement score [NIDA]

Term Description

The NIDA-Modified ASSIST Substance Involvement (SI) Score informs the patient's risk level for illicit or nonmedical prescription drug use. A SI score of 0-3 indicates Lower Risk; 4-26 indicates Moderate Risk; and 27 or greater indicates High Risk.
Source: National Institute on Drug Abuse

Fully-Specified Name

Component
Other substance involvement score
Property
Score
Time
Pt
System
^Patient
Scale
Qn
Method
NIDA

Basic Attributes

Class
SURVEY.NIDA
Type
Surveys
First Released
Version 2.69
Last Updated
Version 2.69
Order vs. Observation
Observation

Member of these Panels

LOINC Long Common Name
95513-8 NIDA-Modified ASSIST version 2.0 [NIDA]

Example Units

Unit Source
{score} Example UCUM Units